Crossref
Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio
Clinical Laboratory · 2023
DOI: 10.7754/clin.lab.2023.230204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2023. Verfasst von ManChun Yuan und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, End Stage Liver Disease, Hepatitis B. Die Arbeit wurde bisher 12-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Hepatitis B, ChronicEnd Stage Liver DiseaseHepatitis BHumansHepatitis B virusLiver CirrhosisRetrospective StudiesMonocytesSeverity of Illness IndexPrognosisAlbumins
Substanzen
Albumins
Zitieren
APA
Yuan, M., Mao, W. E., He, X., & Zhang, Q. (2023). Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2023.230204
Vancouver
Yuan M, Mao WE, He X, Zhang Q. Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2023.230204
BibTeX
@article{Yuan2023,
author = {Yuan, ManChun and Mao, W eiLin and He, Xia and Zhang, Qiu},
title = {Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio},
journal = {Clinical Laboratory},
year = {2023},
doi = {10.7754/clin.lab.2023.230204}
}
EUVIMED